Table 1 Combined ZAP-70 and CD38 expression within clinical parameters
Parameter(s) | Concordant | Discordant | P* value | |
|---|---|---|---|---|
+VE no (%) | −VE no (%) | No (%) | ||
Gender | ||||
Male | 16 (80.0%) | 38 (71.7%) | 25 (67.6%) | 0.71 |
Female | 4 (20.0%) | 15 (27.3%) | 12 (32.4%) | |
Lymphadenopathy | 16 (80.0%) | 34 (64.2%) | 28 (75.7%) | 0.30 |
Splenomegaly | 14 (61.1%) | 20 (43.2%) | 20 (63.4%) | 0.03 |
Hepatomegaly | 4 (20.0%) | 7 (13.2%) | 3 (8.1%) | 0.43 |
No. of lymph areas involved | ||||
≤ 3 | 12 (60%) | 34 (64.2%) | 19 (51.4%) | 0.55 |
> 3 | 8 (40%) | 19 (35.8%) | 18 (48.6%) | |